Featured News
-
Phillips-Medisize Unveils Aria Smart Autoinjector Platform To Drive Innovation And Sustainability In Digital Drug Delivery
5/26/2021
Phillips-Medisize, a Molex company and leader in drug delivery, diagnostic and MedTech devices, today unveiled the Aria Smart Autoinjector platform to unlock innovation, differentiation and sustainability in the digital drug-delivery device market.
-
Phillips-Medisize Enhances Integrated Connected Health Platform
7/26/2018
Phillips-Medisize, a Molex company, announced the release of its third generation connected health platform, a service offering for its pharma and drug delivery device clients. The platform builds on the success of the company’s first connected health solutions, including the first FDA-approved combination product for medication adherence, and incorporates more than a decade of experience in developing connected health solutions.
-
Phillips-Medisize Presents Innovative Packaging Concepts And Connected Drug Delivery Devices During Pharmapack Paris
1/30/2018
Phillips-Medisize, a Molex company will showcase its continuum of contract services including device strategy, product development and manufacture across pharmaceutical primary packaging and specialty drug delivery devices, dosing & dispensing systems, inhalators, spray applicators, as well as wearable drug delivery devices designed to improve patient engagement and drive better outcomes.
-
Dance Biopharm And Phillips-Medisize Enter Into Joint Development Agreement For Advanced Inhaled Insulin Delivery
12/5/2017
Dance Biopharm Holdings Inc. (“Dance”), a privately-held biotechnology company focused on the development of Dance 501, a proprietary ‘soft-mist’ inhaled insulin product to treat diabetes, is pleased to announce that Dance has entered into a joint development agreement (JDA) with Phillips-Medisize, LLC, a subsidiary of Molex Electronic Technologies, LLC, a leader in electronic solutions, to develop a version of the Dance 501 device that has data connectivity for better management of diabetes treatment.
-
Flexicare (Group) Limited Acquires Medisize B.V.
11/21/2017
Flexicare (Group) Limited (“Flexicare”), a leading UK headquartered manufacturer of medical devices, is pleased to announce that it has acquired Medisize B.V. from an affiliate of Phillips-Medisize, LLC (“Phillips-Medisize”).
-
Phillips-Medisize And Molex At Compamed: One Team, Infinite Possibilities
11/13/2017
Phillips-Medisize, a Molex company, will be exhibiting at K39 in hall 8a during COMPAMED 2017. COMPAMED takes place simultaneously with the Medica exhibition on November 13-16 in Düsseldorf. Come visit the booth to see the expanded and integrated Phillips-Medisize and Molex capabilities.
-
Phillips-Medisize Announces FDA Approval Of myBETApp And BETACONNECT Navigator
10/18/2017
Phillips-Medisize, LLC (Phillips-Medisize) is honored to announce Bayer’s recent approval from the U.S. Food and Drug Administration (FDA) for the myBETAapp™ and BETACONNECT™ Navigator. Phillips-Medisize designed and developed the BETACONNECT autoinjector, myBETAapp and the BETACONNECT Navigator via its Medicom device strategy and design services group.
-
Connectivity – Key To Future-Oriented Medical Care
3/24/2017
Phillips-Medisize’s stand 1E28 at Medtec Europe, Stuttgart/Germany, April 4th to 6th, 2017, is designed for medical device professionals to discuss future products – from the first idea through to engineered-in scalability and batch production respectively. Several display cases reveal a clear view of numerous medical, diagnostic and drug delivery devices. They serve the discussion partners – potential customers, OEM manufacturers and the experts from Phillips-Medisize – as illustrative material to determine the typical steps and processes from the first model component to the ready-for-use solution.
-
Phillips-Medisize To Participate In Panel At Partnership Opportunities In Drug Delivery (PODD)
10/24/2016
Phillips-Medisize Corporation, is once again a sponsor and will present during a panel discussion at the upcoming Partnership Opportunities in Drug Delivery (PODD) conference in Boston, MA.
-
Showcasing Connected Health Capabilities At PDA Universe Of Pre-Filled Syringes And Injection Devices Conference
10/14/2016
Phillips-Medisize Corporation, along with Medicom Innovation Partner (“Medicom”) will showcase their capabilities at next week’s PDA Universe of Pre-filled Syringes and Injection Devices conference in Huntington Beach, CA. This conference brings together industry and regulatory experts to share their experiences with the benefits, convenience and innovations pre-filled syringes and injection devices.